Young-age patients with NSCLC had a greater extent of malignancy and mortality rate than elderly patients [40], and most of the young-aged lung cancer patients had ADC [41], all of which may contribute to the negative relationship between the S100A4 expression and age. The gene discussed is S100A4; the disease is non-small cell lung carcinoma.